japotheca ltd

Live MatureSmallLow

japotheca ltd Company Information

Share JAPOTHECA LTD

Company Number

05017808

Directors

Jonathan Cox

Shareholders

jonathan william cox

Group Structure

View All

Industry

Dispensing chemist in specialised stores

 

Registered Address

62 high street, hampton hill, hampton, middlesex, TW12 1PD

Website

-

japotheca ltd Estimated Valuation

£544.3k

Pomanda estimates the enterprise value of JAPOTHECA LTD at £544.3k based on a Turnover of £1.6m and 0.33x industry multiple (adjusted for size and gross margin).

japotheca ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of JAPOTHECA LTD at £0 based on an EBITDA of £-16.9k and a 3.8x industry multiple (adjusted for size and gross margin).

japotheca ltd Estimated Valuation

£110.2k

Pomanda estimates the enterprise value of JAPOTHECA LTD at £110.2k based on Net Assets of £52.8k and 2.09x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Japotheca Ltd Overview

Japotheca Ltd is a live company located in middlesex, TW12 1PD with a Companies House number of 05017808. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in January 2004, it's largest shareholder is jonathan william cox with a 100% stake. Japotheca Ltd is a mature, small sized company, Pomanda has estimated its turnover at £1.6m with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Japotheca Ltd Health Check

Pomanda's financial health check has awarded Japotheca Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating1.5out of 5
positive_score

1 Strong

positive_score

4 Regular

positive_score

7 Weak

size

Size

annual sales of £1.6m, make it smaller than the average company (£13.4m)

£1.6m - Japotheca Ltd

£13.4m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (7.7%)

1% - Japotheca Ltd

7.7% - Industry AVG

production

Production

with a gross margin of 31.6%, this company has a comparable cost of product (31.6%)

31.6% - Japotheca Ltd

31.6% - Industry AVG

profitability

Profitability

an operating margin of -2.5% make it less profitable than the average company (2.6%)

-2.5% - Japotheca Ltd

2.6% - Industry AVG

employees

Employees

with 17 employees, this is below the industry average (70)

17 - Japotheca Ltd

70 - Industry AVG

paystructure

Pay Structure

on an average salary of £28.3k, the company has an equivalent pay structure (£28.3k)

£28.3k - Japotheca Ltd

£28.3k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £96.6k, this is less efficient (£147.3k)

£96.6k - Japotheca Ltd

£147.3k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 30 days, this is near the average (29 days)

30 days - Japotheca Ltd

29 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 75 days, this is slower than average (60 days)

75 days - Japotheca Ltd

60 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 35 days, this is in line with average (33 days)

35 days - Japotheca Ltd

33 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (13 weeks)

7 weeks - Japotheca Ltd

13 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 86%, this is a higher level of debt than the average (57.9%)

86% - Japotheca Ltd

57.9% - Industry AVG

JAPOTHECA LTD financials

EXPORTms excel logo

Japotheca Ltd's latest turnover from May 2024 is estimated at £1.6 million and the company has net assets of £52.8 thousand. According to their latest financial statements, Japotheca Ltd has 17 employees and maintains cash reserves of £45.6 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010
Turnover1,642,7731,435,7751,269,0411,586,1091,459,2311,034,8491,278,1491,086,4001,123,2511,355,8441,066,1881,002,4841,194,0141,305,8711,192,861
Other Income Or Grants
Cost Of Sales1,124,338967,744839,9121,071,5981,006,758704,707861,674733,927765,266949,228738,549691,162842,568917,376830,214
Gross Profit518,435468,031429,129514,511452,473330,142416,475352,473357,985406,617327,640311,322351,446388,495362,647
Admin Expenses558,842555,361448,949518,969422,892324,309368,864299,598342,352392,417310,729281,161308,761384,211358,668
Operating Profit-40,407-87,330-19,820-4,45829,5815,83347,61152,87515,63314,20016,91130,16142,6854,2843,979
Interest Payable3,9118,9186,0251,018
Interest Receivable4,0065,0309926558321682328130257136774
Pre-Tax Profit-36,401-82,300-18,828-4,39329,6406,15447,67952,89815,66114,33017,16826,38633,774-1,7342,965
Tax-5,632-1,169-9,059-10,051-3,132-2,866-3,605-6,069-8,106-830
Profit After Tax-36,401-82,300-18,828-4,39324,0084,98538,62042,84712,52911,46413,56320,31725,668-1,7342,135
Dividends Paid
Retained Profit-36,401-82,300-18,828-4,39324,0084,98538,62042,84712,52911,46413,56320,31725,668-1,7342,135
Employee Costs481,258429,597333,335332,429313,731232,211243,240225,784211,112208,856171,488152,281151,427182,785150,854
Number Of Employees171714151511121212121099119
EBITDA*-16,899-70,452-19,82010,02443,64720,35661,90767,70431,17230,94035,63247,05460,67223,72924,473

* Earnings Before Interest, Tax, Depreciation and Amortisation

May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010
Tangible Assets54,52820,32123,4415,3474,1025,4684,7916,3878,51611,35515,39511,01015,20320,49024,555
Intangible Assets3,34916,04928,74941,44954,14966,84979,54992,249104,949117,649130,349143,049155,749168,449181,149
Investments & Other5,346507
Debtors (Due After 1 year)
Total Fixed Assets57,87741,71652,69746,79658,25172,31784,34098,636113,465129,004145,744154,059170,952188,939205,704
Stock & work in progress110,041108,041107,040136,725136,289137,289128,289123,185118,185118,685118,595118,789113,789106,289105,301
Trade Debtors137,651111,656100,087181,323175,31088,690154,850133,449149,507155,91094,29887,869175,372174,986152,896
Group Debtors
Misc Debtors25,33435,15131,22513,60116,50920,86212,89918,3533,775
Cash45,628106,992116,57481,82748,79067,28418,2808,7999,5821,72250,34952,6271,5891,0901,725
misc current assets3,183
total current assets318,654365,023354,926413,476376,898314,125314,318283,786281,049276,317263,242259,285290,750282,365259,922
total assets376,531406,739407,623460,272435,149386,442398,658382,422394,514405,321408,986413,344461,702471,304465,626
Bank overdraft78,75077,04131,320
Bank loan
Trade Creditors 231,255194,466199,385195,031170,851173,622148,272155,525161,184332,538347,174363,382314,552315,723320,734
Group/Directors Accounts101,322
other short term finances
hp & lease commitments
other current liabilities89,339123,09236,75774,26369,24041,60384,38199,33847,048
total current liabilities320,594317,558236,142269,294240,091215,225232,653254,863309,554332,538347,174363,382393,302392,764352,054
loans41,58677,013
hp & lease commitments
Accruals and Deferred Income
other liabilities3,095110,362
provisions3,1576693565232964707181,0701,563181445826775
total long term liabilities3,1576693565232964707181,0701,5633,27642,03177,839111,137
total liabilities323,751317,558236,142269,963240,447215,748232,949255,333310,272333,608348,737366,658435,333470,603463,191
net assets52,78089,181171,481190,309194,702170,694165,709127,08984,24271,71360,24946,68626,3697012,435
total shareholders funds52,78089,181171,481190,309194,702170,694165,709127,08984,24271,71360,24946,68626,3697012,435
May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010
Operating Activities
Operating Profit-40,407-87,330-19,820-4,45829,5815,83347,61152,87515,63314,20016,91130,16142,6854,2843,979
Depreciation10,8084,1781,7821,3661,8231,5962,1292,8394,0406,0214,1935,2876,7457,794
Amortisation12,70012,70012,70012,70012,70012,70012,70012,70012,70012,70012,70012,70012,70012,700
Tax-5,632-1,169-9,059-10,051-3,132-2,866-3,605-6,069-8,106-830
Stock2,0001,001-29,685436-1,0009,0005,1045,000-50090-1945,0007,500988105,301
Debtors16,17815,495-63,6123,10582,267-58,19715,947-1,480-2,62861,6126,429-87,50338622,090152,896
Creditors36,789-4,9194,35424,180-2,77125,350-7,253-5,659-171,354-14,636-16,20848,830-1,171-5,011320,734
Accruals and Deferred Income-33,75386,335-37,5065,02327,637-42,778-14,95752,29047,048
Deferred Taxes & Provisions3,157-669313-167227-174-248-352-4931,382-264-38151775
Cash flow from operations-28,884-5,53239,65635,999-18,55351,1839,413100,516-93,490-48,75710,966172,05443,128-4,30986,955
Investing Activities
capital expenditure-45,015-1,058-5,394-3,027-2,500-10,406-2,680-226,198
Change in Investments-5,3464,839507
cash flow from investments-39,669-5,897-5,901-3,027-2,500-10,406-2,680-226,198
Financing Activities
Bank loans
Group/Directors Accounts-101,322101,322
Other Short Term Loans
Long term loans-41,586-35,42777,013
Hire Purchase and Lease Commitments
other long term liabilities-3,0953,095-110,362110,362
share issue300
interest4,0065,0309926558321682328130257-3,775-8,911-6,018-1,014
cash flow from financing4,0065,030992655832168-101,299101,350130-2,838-42,266-44,338-39,367109,648
cash and cash equivalents
cash-61,364-9,58234,74733,037-18,49449,0049,481-7837,860-48,627-2,27851,038499-6351,725
overdraft-78,7501,70945,72131,320
change in cash-61,364-9,58234,74733,037-18,49449,0049,481-7837,860-48,627-2,278129,788-1,210-46,356-29,595

japotheca ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for japotheca ltd. Get real-time insights into japotheca ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Japotheca Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for japotheca ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in TW12 area or any other competitors across 12 key performance metrics.

japotheca ltd Ownership

JAPOTHECA LTD group structure

Japotheca Ltd has no subsidiary companies.

Ultimate parent company

JAPOTHECA LTD

05017808

JAPOTHECA LTD Shareholders

jonathan william cox 100%

japotheca ltd directors

Japotheca Ltd currently has 1 director, Mr Jonathan Cox serving since Jan 2004.

officercountryagestartendrole
Mr Jonathan Cox58 years Jan 2004- Director

P&L

May 2024

turnover

1.6m

+14%

operating profit

-40.4k

0%

gross margin

31.6%

-3.19%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

May 2024

net assets

52.8k

-0.41%

total assets

376.5k

-0.07%

cash

45.6k

-0.57%

net assets

Total assets minus all liabilities

japotheca ltd company details

company number

05017808

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

January 2004

age

21

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

May 2024

previous names

N/A

accountant

AEQUITAS

auditor

-

address

62 high street, hampton hill, hampton, middlesex, TW12 1PD

Bank

-

Legal Advisor

-

japotheca ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to japotheca ltd. Currently there are 0 open charges and 2 have been satisfied in the past.

japotheca ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for JAPOTHECA LTD. This can take several minutes, an email will notify you when this has completed.

japotheca ltd Companies House Filings - See Documents

datedescriptionview/download